Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: Are we only looking at tumor necrosis?

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 2, 2014, Pages 317-325

  Chiaradia, Melanie ^a,b   Baranes, Laurence ^a,b   Van Nhieu, Jeanne Tran ^a,b   Vignaud, Alexandre ^c   Laurent, Alexis ^a,b   Decaens, Thomas ^a,b   Charles Nelson, Anaïs ^a   Brugières, Pierre ^a   Katsahian, Sandrine ^a   Djabbari, Marjane ^a   Deux, Jean François ^a,b   Sobhani, Iradj ^a,b   Karoui, Mehdi ^a,b   Rahmouni, Alain ^a,b   Luciani, Alain ^a,b,d  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c Pathology ^*  (France)

^d INSERM U955   (France)

Author keywords

b values; colorectal liver metastases; diffusion weighted imaging; intra voxel incoherent motion; tumor necrosis

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; GADOTERATE MEGLUMINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SIZE; COLORECTAL LIVER METASTASIS; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; INTRAVOXEL INCOHERENT MOTION DIFFUSION WEIGHTED IMAGING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMIC THERAPY; TUMOR NECROSIS; VERY ELDERLY;

B VALUES; COLORECTAL LIVER METASTASES; DIFFUSION WEIGHTED IMAGING; INTRA-VOXEL INCOHERENT MOTION; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; COLON; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MOTION; NECROSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84892712563     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24172     Document Type: Article

References (34)

1. Taouli B, Koh DM,. Diffusion-weighted MR imaging of the liver. Radiology 2010; 254: 47-66.
2. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M,. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: 401-407.
3. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M,. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168: 497-505.
4. Le Bihan D, Turner R, MacFall JR,. Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: application to molecular diffusion imaging. Magn Reson Med 1989; 10: 324-337.
5. Lemke A, Stieltjes B, Schad LR, Laun FB,. Toward an optimal distribution of b values for intravoxel incoherent motion imaging. Magn Reson Imaging 2011; 29: 766-776.
6. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging - pilot study. Radiology 2008; 249: 891-899.
7. Cui Y, Zhang XP, Sun YS, Tang L, Shen L,. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248: 894-900.
8. Koh DM, Scurr E, Collins D, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007; 188: 1001-1008.
9. Dudeck O, Zeile M, Wybranski C, et al. Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur Radiol 2010; 20: 2699-2706.
10. Rubbia-Brandt L, Giostra E, Brezault C, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 2007; 18: 299-304.
11. Lewin M, Poujol-Robert A, Boelle PY, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007; 46: 658-665.
12. Danet IM, Semelka RC, Leonardou P, et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 2003; 181: 809-817.
13. Couinaud C,. [Definition of hepatic anatomical regions and their value during hepatectomy (author's transl)]. Chirurgie 1980; 106: 103-108.
14. Soyer P,. Segmental anatomy of the liver: utility of a nomenclature accepted worldwide. AJR Am J Roentgenol 1993; 161: 572-573.
15. Cherqui D, Husson E, Hammoud R, et al. Laparoscopic liver resections: a feasibility study in 30 patients. Ann Surg 2000; 232: 753-762.
16. Thoeny HC, De Keyzer F, Vandecaveye V, et al. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 2005; 237: 492-499.
17. Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B,. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 2010; 31: 589-600.
18. Pekar J, Moonen CT, van Zijl PC,. On the precision of diffusion/perfusion imaging by gradient sensitization. Magn Reson Med 1992; 23: 122-129.
19. Yoshino N, Yamada I, Ohbayashi N, et al. Salivary glands and lesions: evaluation of apparent diffusion coefficients with split-echo diffusion-weighted MR imaging - initial results. Radiology 2001; 221: 837-842.
20. Koh DM, Collins DJ, Orton MR,. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 2011; 196: 1351-1361.
21. Lemke A, Laun FB, Simon D, Stieltjes B, Schad LR,. An in vivo verification of the intravoxel incoherent motion effect in diffusion-weighted imaging of the abdomen. Magn Reson Med 2010; 64: 1580-1585.
22. Soyer P, Corno L, Boudiaf M, et al. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging. Eur J Radiol 2011; 80: 316-324.
23. Miller FH, Hammond N, Siddiqi AJ, et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 2010; 32: 138-147.
24. Wagner M, Doblas S, Daire JL, et al. Diffusion-weighted MR imaging for the regional characterization of liver tumors. Radiology 2012; 264: 464-472.
25. Goshima S, Kanematsu M, Kondo H, et al. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008; 28: 691-697.
26. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008; 246: 812-822.
27. Coenegrachts K, Delanote J, Ter Beek L, et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 2007; 80: 524-531.
28. Coenegrachts K, Delanote J, Ter Beek L, et al. Evaluation of true diffusion, perfusion factor, and apparent diffusion coefficient in non-necrotic liver metastases and uncomplicated liver hemangiomas using black-blood echo planar imaging. Eur J Radiol 2009; 69: 131-138.
29. Hardie AD, Naik M, Hecht EM, et al. Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol 2010; 20: 1431-1441.
30. Soyer P, Boudiaf M, Place V, et al. Preoperative detection of hepatic metastases: comparison of diffusion-weighted, T2-weighted fast spin echo and gadolinium-enhanced MR imaging using surgical and histopathologic findings as standard of reference. Eur J Radiol 2011; 80: 245-252.
31. Chun YS, Vauthey JN, Boonsirikamchai P, et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 2009; 302: 2338-2344.
32. De Bruyne S, Van Damme N, Smeets P, et al. Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases. Br J Cancer 2012; 106: 1926-1933.
33. Poultsides GA, Bao F, Servais EL, et al. Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome. Ann Surg Oncol 2012; 19: 2797-2804.
34. Chang HH, Leeper WR, Chan G, Quan D, Driman DK,. Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy. Am J Surg Pathol 2012; 36: 570-576.